Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic Implications.

Ish-Shalom E., Meirow Y., Sade-Feldman M., Kanterman J., Wang L., Mizrahi O., Klieger Y., Baniyash M.
Journal of. Immunology., 2016, 196: 156-167
Full PDF

Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes.

Kanterman J., Sade-Feldman M., Biton M., Ish-Shalom E., Lasry A., Goldshtein A., Hubert A. and Baniyash M.
Cancer Research. Nov 2014; 74(21):6022-35
Full PDF

Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.

Sade-Feldman M., Kanterman J., Klieger Y., Ish-Shalom E., Olga M., Saragovi A., Shtainberg H., Lotem M., Baniyash M.
Clinical Cancer Research; 2016, 22(23); 5661-72
Full PDF

Myeloid Derived Suppressor Cells as Intruders and Targets: Clinical Implications in Cancer Therapy

Baniyash M.
Cancer Immunology, Immunotherapy, Jul. 2016, 65(7): 857–867
Full PDF

Chronic Inflammation, Immunosuppression and Cancer: New Insights and Outlook.

Baniyash M.
Seminars in Cancer Biology, Feb 2006, 16(1):80-88.
Full PDF

CD247, a Novel T Cell-Derived Diagnostic and Prognostic Biomarker for Detecting Disease Progression and Severity in Patients with Type 2 Diabetes Mellitus

Eldor R., Klieger Y., Sade-Feldman M., Vaknin I., Varfolomeev I., Fuchs C. and Baniyash M.
Diabetes Care, Jan. 2015; 38(1): 113-118
Full PDF

Immune Biomarkers for Chronic Inflammation Related Complications in Non-Cancerous and Cancerous Diseases

Meirow Y., Baniyash M.
Cancer Immunology, Immunotherapy, Aug. 2017, 66(8): 1089–1101
Full PDF

Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate.

Meirow Y., Kanterman J. and Baniyash M
Frontiers in Immunology, Oct. 2015; 6: Art. 523:1-12
Full PDF

Sustained Exposure to Bacterial Antigen Induces Interferon-γ-Dependent T Cell Receptor ζ Down-Regulation and Impaired T Cell Function

Bronstein-Sitton N., Cohen-Daniel L., Vaknin I., Ezernitchi V., Leshem B., Halabi A., Houri-Hadad Y., Greenbaum E., Zakay-Rones Z., Shapira L. & Baniyash M.
Nature Immunology, Oct. 2003, Vol. 4 (10): 957-964
Full PDF

TCR Zeta-Chain Downregulation: Curtailing an Excessive Inflammatory Immune Response.

Baniyash M.
Nature Reviews, Immunology, Sep. 2004, 4: 675-687.
Full PDF

New Insights into Chronic Inflammation-Induced Immunosuppression

Kanterman J., Sade-Feldman M. , Baniyash M.
Seminars in Cancer Biology, Aug. 2012 (4):307-318
Full PDF

Unique ζ-Chain Motifs Mediate a Direct TCR-Actin Linkage Critical for Immunological Synapse Formation and T-Cell Activation.

Klieger Y., Almogi-Hazan O., Ish-Shalom E., Pato A., Pauker M.H., Barda-Saad M., Wang L., Baniyash M.
European Journal of Immunology, Jan. 2014; 44(1): 58-68.
Full PDF

TCR Zeta Down-Regulation under Chronic Inflammation is mediated by Myeloid Suppressor Cells Differentially Distributed between Various Lymphatic Organs.

Ezernitchi A.V., Vaknin I., Cohen-Daniel L., Levy O., Manaster E., Halabi A., Pikarsky E., Shapira L., Baniyash M.
The Journal of Immunology, Oct. 2006, 177(7): 4763-4772.
Full PDF

Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells During Chronic Inflammation.

Sade-Feldman M., Kanterman J., Ish-Shalom E., Elnekave M., Horwitz E., Baniyash M.
Immunity, Mar. 2013, 38(3): 541-554
Full PDF

Chronic Inflammation and Cancer: Suppressing the Suppressors

Baniyash M., Sade-Feldman M., Kanterman J.
Cancer Immunology. Immunotherapy, Jan. 2014, 63(1): 11-20
Full PDF

Cyclophosphamide Promotes Chronic Inflammation-Dependent Immunosuppression and Prevents Antitumor Response in Melanoma.

Sevko A., Sade-Feldman M., Kanterman J., Michels T., Falk C.S., Umansky L., Ramacher M., Kato M., Schadendorf D., Baniyash M., Umansky V.
Journal of Investigative Dermatology, Jun. 2013, 133(6):1610-1619.
Full PDF

Chronic Inflammation Promotes Myeloid-Derived Suppressor Cell Activation Blocking Antitumor Immunity in Transgenic Mouse Melanoma Model

Meyer C., Sevko A., Ramacher M., Bazhin A.V., Falk C.S., Osen W., Borrello I., Kato M., Schadendorf D., Baniyash M., Umansky V.
Proceedings of the National Academy of Sciences of the USA (PNAS), Oct. 2011, 108(41): 17111-7116.
Full PDF

Quantitative Flow Cytometry: Concerns and Recommendations in Clinic and Research

Mizrahi O., Ish Shalom E., Baniyash M., Kliege Y.
Clinical Cytometry, Cytometry Part B, Feb. 2017, 94(2).
Full PDF

Expression of the T Cell Antigen Receptor Z Chain Following Activation Is Controlled at Distinct Checkpoints Implications for Cell Surface Receptor Down-Modulation and Re-Expression

Bronstein-Sitton N., Wang L., Cohen L., and Baniyash M.
The Journal of Biological Chemistry, Aug. 1999, Vol. 274(33): 23659–23665
Full PDF

Molecular Cloning of the Zeta Chain of the T Cell Antigen Receptor.

Weissman A.M., Baniyash M., Hou D., Samelson L.E., Burgess W.H., Klausner R.D.
Science, Feb. 1988, 239(4843):1018-1021
Full PDF

The Role of the Zeta Chain in the Expression, Structure and Function of the T Cell Receptor

Klausner R.D., Weissman A.M., Baniyash M., Bonifacino J.S., Samelson L.E.
Mechanisms of Lymphocyte Activation and Immune Regulation II, 1989, 254: 21-24.
Full PDF
Scroll to top
Skip to content